JPH0686389B2 - Anti-UV-induced mutagenic agent derived from Yashabushi fruit - Google Patents
Anti-UV-induced mutagenic agent derived from Yashabushi fruitInfo
- Publication number
- JPH0686389B2 JPH0686389B2 JP63271820A JP27182088A JPH0686389B2 JP H0686389 B2 JPH0686389 B2 JP H0686389B2 JP 63271820 A JP63271820 A JP 63271820A JP 27182088 A JP27182088 A JP 27182088A JP H0686389 B2 JPH0686389 B2 JP H0686389B2
- Authority
- JP
- Japan
- Prior art keywords
- chloroform
- condensed tannin
- ethanol
- insoluble
- extracted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
Description
【発明の詳細な説明】 〔発明の目的〕 本発明は、抗突然変異作用剤:バイオアンチミュータジ
エンの新規な開発に関する。DETAILED DESCRIPTION OF THE INVENTION [Object of the Invention] The present invention relates to a novel development of an antimutagenic agent: bioantimutadiene.
さらに詳しくは、原料起源がカバノキ科の植物であるヤ
シャブシ(Alnus firma)の堅果、すなわち生薬名称
「矢車」の実から抽出されるある特定な理化学的性質を
有する縮合型タンニン分画を有効成分とする新規な抗紫
外線誘発突然変異作用剤に関する。More specifically, the raw material origin is a nut of Yashabushi (Alnus firma), which is a plant of the family Birchaceae, that is, a condensed tannin fraction having a certain physicochemical property extracted from the fruit of the crude drug name "Yaguruma" as an active ingredient. The present invention relates to a novel anti-ultraviolet-induced mutagenesis agent.
「産業上の利用分野」 本発明によるヤシャブシの実由来の縮合型タンニン分画
は、紫外線によって損傷をきたしたDNAに対し優れた修
復・改善作用を有する。"Industrial field of application" The condensed tannin fraction derived from the pods of the present invention has an excellent repair / improvement effect on DNA damaged by ultraviolet rays.
よって本剤は、例えば、医薬品、医薬部外品、化粧品、
食品(健康食品)などに用いることができる。具体的に
は、人体或は動物用の医薬品、食品(健康食品や家畜用
飼料)、化粧品などに配合して用いることによって、紫
外線により変異した組織細胞に対しての改善や、あるい
はその予防を期待して利用することができる。Therefore, this drug is, for example, medicines, quasi drugs, cosmetics,
It can be used for foods (health foods). Specifically, it can be used in combination with pharmaceuticals for humans or animals, foods (health foods and feeds for livestock), cosmetics, etc. to improve or prevent the tissue cells mutated by ultraviolet rays or prevent them. It can be used as expected.
「従来の技術」 細胞の突然変異に関する研究は、これまでに数々の研究
者らによって行われてきており、既に、種々の変異原性
因子が確認されている。これら因子が一つの原因となっ
て細胞の癌化を誘発することは広く認識されている通り
である。“Prior Art” Studies on cell mutations have been conducted by many researchers so far, and various mutagenic factors have already been confirmed. It is widely recognized that one of these factors causes canceration of cells.
一方、最近では、こうした研究によって抗変異原性作用
を有した物質の存在も発見されてきており、この分野に
おける研究動向は非常に注目されるようになってきた。On the other hand, recently, the existence of a substance having an antimutagenic effect has been discovered by such research, and the research trend in this field has been receiving much attention.
例えば、DNA修復に関するこれまでの研究動向は、武部
啓著「DNA修復」,財団法人東京大学出版会(1987年3
月31日)などに詳しく説明されている。For example, the research trend up to now on DNA repair is written by Kei Takebe, "DNA Repair", The University of Tokyo Press (March 1987).
31st month) and so on.
この分野の研究においては、特に、大腸菌を用いた研究
が進んでおり、分子レベルでの修復メカニズムといった
ことまで解明されてきた。In this field of research, research using Escherichia coli has been particularly advanced, and the repair mechanism at the molecular level has been elucidated.
そして、種々の研究結果から、大腸菌とヒト細胞では突
然変異及びその修復機構にいくらかの共通性が認められ
たという興味深い知見についても報告されている。And, from various research results, interesting findings that Escherichia coli and human cells were found to have some commonality in mutation and its repair mechanism were reported.
こうした研究成果によって、微生物を用いた簡易な抗変
異原性作用因子の検索法が提唱され、現在に至り、これ
に関する研究は、がんの予防や抑制への可能性といった
ことなどから重要なテーマとしてとり上げられ広く行わ
れるようになってきた。Based on these research results, a simple search method for antimutagenic agents using microorganisms has been proposed, and up to the present, research on this is an important theme because of its potential for prevention and suppression of cancer. It has been widely adopted as
突然変異頻度の測定法については、例えば、望月、賀田
らによる研究論文(Mutation Research,95,P457−474
(1982))や、能美らによる記事(トキシコロジーフォ
ーラム,9(2),P189−198(1986))などに詳しく説明
されており、特に、大腸菌を用いた検討法が代表的な一
つとして示されている。Regarding the method for measuring the mutation frequency, for example, a research paper by Mochizuki, Kada et al. (Mutation Research, 95, P457-474)
(1982)) and an article by Nomi et al. (Toxicology Forum, 9 (2), P189-198 (1986)), etc., and in particular, the examination method using E. coli is shown as a typical example. Has been done.
そこで、本発明者らは、種々の変異原性因子の中でも、
最も広く一般的に被線している環境因子の紫外線をとり
上げ、これによって誘発された大腸菌の突然変異に対
し、その修復・改善的作用を有する物質の検索に着手
し、標記のような利用分野に役立つような製剤の開発に
あたった。Therefore, the present inventors, among various mutagenic factors,
We picked up ultraviolet rays, which is the most widely exposed environmental factor, and started to search for substances that have a repairing / improving effect on the mutation of Escherichia coli induced by the ultraviolet rays. We have developed a formulation that is useful for
「発明が解決しようとする課題」 すなわち、本発明者らは抗紫外線誘発突然変異作用をも
った物質を、天然産物:植物中に求め、それに関する製
剤の開発にあたることを課題となし、鋭意研究を続けて
きたのである。[Problems to be Solved by the Invention] That is, the present inventors have made an earnest research by finding a substance having an anti-UV-induced mutation in a natural product: a plant, and developing a formulation related thereto. Has continued.
その過程で、カバノキ科の植物であるヤシャブシ(Alnu
s firma)の堅果である「矢車」の実から得られた抽出
物中に、効率の良いDNA修復作用をもつバイオアンチミ
ュータジエンが存在することを見い出すに至った。In the process, Birch (Alnu)
s firma), an extract obtained from the fruit of "Yaguruma", which is a nut, has been found to contain bioantimutadiene with an efficient DNA repair action.
そこで、これが如何なる成分であるか、その同定に当っ
たところ、以下に示すごとくの理化学的手段をもって特
定することができ、本発明を完成した。Then, when the identification of what component this is, it was possible to identify it by the physicochemical means as shown below, and the present invention was completed.
本発明は、カバノキ科植物のヤシャブシの堅実:矢車か
ら得られた、次の(a)〜(c)の特性を有する縮合型
タンニン分画(以下、C−1という)を有効成分とする
抗紫外線誘発変異作用剤と (a)水に易溶、エタノール、酢酸エチル、クロロホル
ムには不溶。The present invention relates to the solidity of Birch of the family Birchaceae: anti-condensation type tannin fraction (hereinafter, referred to as C-1) having the following characteristics (a) to (c), obtained from an arrow wheel as an active ingredient. UV-induced mutagenic agent and (a) readily soluble in water, insoluble in ethanol, ethyl acetate, chloroform.
(b)アセチル体となすとき、その分子量が3,500〜5,5
00にある。(B) When made into an acetyl form, its molecular weight is 3,500 to 5,5.
It's at 00.
(c)薄層クロマトグラムのRf値が0.35付近。(C) The Rf value of the thin-layer chromatogram is around 0.35.
薄層板:254nm UV光下蛍光発色型親水性シリカゲルプレ
ート 展開溶媒:クロロホルム:メタノール:酢酸(3:2:0.
2)混液 同じく、カバノキ科植物のヤシャブシの実から抽出され
た、次の(a)〜(c)の特性を有する縮合型タンニン
分画(以下C−3という)を有効成分とする抗紫外線誘
発変異作用剤と、 (a)水にやや難溶、エタノールに易溶、酢酸エチル、
クロロホルムには不溶。Thin layer plate: 254nm UV fluorescent hydrophilic silica gel plate Developing solvent: Chloroform: Methanol: Acetic acid (3: 2: 0.
2) Mixed solution Similarly, an anti-ultraviolet ray induction using a condensed tannin fraction (hereinafter referred to as C-3) having the following characteristics (a) to (c), which is extracted from the seeds of Birchgrass of the family Birchaceae, as an active ingredient Mutagenic agent, (a) slightly soluble in water, easily soluble in ethanol, ethyl acetate,
Insoluble in chloroform.
(b)アセチル体となすとき、その分子量が2,500〜3,2
00にある。(B) When made into an acetyl form, its molecular weight is 2,500 to 3,2.
It's at 00.
(c)薄層クロマトグラムのRf値が0.54付近。(C) The Rf value of the thin-layer chromatogram is around 0.54.
薄層板:254nm UV光下蛍光発色型親水性シリカゲルプレ
ート 展開溶媒:クロロホルム:メタノール:酢酸(3:2:0.
2)混液 標記2種の縮合型タンニン分画の混合物を有効成分とす
る抗紫外線誘発突然変異作用剤をもってなる。Thin layer plate: 254nm UV fluorescent hydrophilic silica gel plate Developing solvent: Chloroform: Methanol: Acetic acid (3: 2: 0.
2) Mixed solution It contains an anti-ultraviolet-induced mutagenizing agent containing a mixture of the above-mentioned two condensed tannin fractions as an active ingredient.
「課題を解決するための手段」 〔1〕粗抽出物の製造法 カバノキ科植物のヤシャブシの堅実:矢車の実を粉砕
し、60%−エタノールに室温で一晩浸漬させた後、80℃
で1時間の加熱抽出を行い、冷却、濾過して濾液を得
る。[Means for Solving the Problems] [1] Method for Producing Crude Extract Steady of Birch Spodoptera: Nuts of Yarrows are crushed and immersed in 60% -ethanol overnight at room temperature, and then at 80 ° C.
The mixture is subjected to heat extraction for 1 hour, cooled and filtered to obtain a filtrate.
濾過の際に得られた残渣は、再び、上記の操作に従って
2回行い、その濾液を混合し減圧濃縮を行う。The residue obtained during filtration is again subjected to the above operation twice, and the filtrates are mixed and concentrated under reduced pressure.
尚、減圧濃縮は濾液中に含まれるエタノールが完全に除
去されるまで行い、水懸濁液又は乾固した状態にする。The concentration under reduced pressure is carried out until the ethanol contained in the filtrate is completely removed, and the suspension is made into an aqueous suspension or dried.
次に、この水懸濁化状態又は乾固粉末状態となしたもの
に対して、クロロホルムを加えて撹拌しその水溶層部又
は残渣部を分取して、減圧濃縮による乾燥を行い、粗タ
ンニン粉末を得る。Next, to the water-suspended state or dry-solid powder state, chloroform is added and stirred, and the water-soluble layer portion or the residual portion is separated and dried by vacuum concentration to obtain crude tannin. Get a powder.
〔2〕精製分離法 前記工程で得られた粗タンニン粉末を、加温した無水エ
タノール(60℃)中に溶解後、冷却し、遠心分離機にか
けて、その上清部と沈殿部に分別(分画)をはかる。[2] Purification and Separation Method The crude tannin powder obtained in the above step is dissolved in warm anhydrous ethanol (60 ° C.), cooled, and then centrifuged to separate it into a supernatant portion and a precipitation portion (separation). Drawing).
すなわち、ここで分画された沈殿部は本発明による粗C
−1に該当し、上清部は粗C−3に該当する。That is, the sedimentation fraction fractionated here is the crude C according to the present invention.
-1, and the supernatant part corresponds to crude C-3.
沈殿部は乾燥後、少量の水をもって完全に溶解させ、次
に3倍量のエタノールを加え冷暗所において一晩放置す
る。これによって、析出した沈殿物を回収して、C−1
を得ることが出来る。After drying the precipitated part, it is completely dissolved with a small amount of water, then 3 times the amount of ethanol is added and left overnight in a cool dark place. In this way, the deposited precipitate is recovered, and C-1
Can be obtained.
また上清部は減圧乾固を行い、次に少量の無水エタノー
ルに完全に溶解させた後、3倍量のクロロホルムを加え
て冷暗所に一晩放置する。これによって析出した沈殿物
を回収し、C−3を得る。The supernatant is dried under reduced pressure, completely dissolved in a small amount of absolute ethanol, added with 3 volumes of chloroform, and left in a cool dark place overnight. The precipitate thus deposited is collected to obtain C-3.
〔3〕理化学的性質に関する試験結果 <A>呈色反応 C−1及びC−3は、塩化第二鉄試液により、C−1は
藍灰色、C−3は暗緑色を呈し、n−ブタノール中にお
いて、塩酸を加えて加熱する時、アントシアニジン様の
淡赤色を呈する。[3] Test results relating to physicochemical properties <A> Color reaction C-1 and C-3 are ferric chloride reagent solutions, C-1 is indigo gray, C-3 is dark green, and n-butanol is used. When heated by adding hydrochloric acid therein, an anthocyanidin-like pale red color is exhibited.
<B>赤外部吸収スペクトル C−1及びC−3のKBr法による赤外線吸収スペクトル
(第1図はC−1、第2図はC−3を示す)から、水酸
基、カルボニル基、ベンゼン環特有のピークが確認さ
れ、縮合型タンニンの特徴が示されている。<B> Infrared absorption spectrum From the infrared absorption spectra of C-1 and C-3 by the KBr method (Fig. 1 shows C-1 and Fig. 2 shows C-3), hydroxyl group, carbonyl group, benzene ring specific Is confirmed, and the characteristics of condensed tannin are shown.
<C>溶剤に対する溶解性 C−1は水溶性であり、且つエタノール、酢酸エチル、
クロロホルムに不溶である。<C> Solubility in Solvent C-1 is water-soluble and contains ethanol, ethyl acetate,
Insoluble in chloroform.
C−3はエタノールに易溶、且つ水に難溶性であり、酢
酸エチル、クロロホルムに不溶である。C-3 is easily soluble in ethanol, sparingly soluble in water, and insoluble in ethyl acetate and chloroform.
<D>薄層クロマトグラム (1) 254nm UV光下蛍光発色型親水性シリカゲルプレート(製
品名:シリカゲル60F254)において、展開溶媒として、
クロロホルム:メタノール:酢酸(3:2:0.2)を使用し
た場合、C−1のRf値は0.35付近、また、C−3のRf値
は0.54付近であった。<D> Thin Layer Chromatogram (1) As a developing solvent in a hydrophilic silica gel plate (product name: silica gel 60F 254 ) that emits fluorescence under 254 nm UV light,
When chloroform: methanol: acetic acid (3: 2: 0.2) was used, the Rf value of C-1 was around 0.35, and the Rf value of C-3 was around 0.54.
(2) C−3は、254nm UV光下蛍光発色型親油性アルキルシリ
カゲルプレート(製品名:HPTLC RP−8F254)において、
展開溶媒として、n−ヘキサン:エタノール(4:1)を
用いて行うとき、そのRf値は、0.52〜0.62である。(2) C-3 is a lipophilic alkyl silica gel plate (product name: HPTLC RP-8F 254 ) that emits fluorescent light under 254 nm UV light,
When using n-hexane: ethanol (4: 1) as a developing solvent, the Rf value is 0.52 to 0.62.
<E>分子量測定試験 C−1及びC−3は縮合型タンニンであることから、通
常のゲル濾過法では多くのフェノール性水酸基により吸
着してしまい、測定は不可能である。<E> Molecular weight measurement test Since C-1 and C-3 are condensed tannins, they are adsorbed by many phenolic hydroxyl groups by a usual gel filtration method and cannot be measured.
よって、本試験に当ってはすべてのフェノール性水酸基
をアセチル化して、分子量の測定に当った。Therefore, in this test, all phenolic hydroxyl groups were acetylated to measure the molecular weight.
(1)アセチル化法 C−1及びC−3のアセチル化は、無水酢酸、ピリジン
によって行い、その得られたアセチル化体の確認につい
ては、溶液法(クロロホルム)による赤外線吸収スペク
トル(第3図は、C−1のアセチル化体、第4図は、C
−3のアセチル化体を示す)により行った。(1) Acetylation method Acetylation of C-1 and C-3 was performed with acetic anhydride and pyridine, and the obtained acetylated product was confirmed by an infrared absorption spectrum by a solution method (chloroform) (Fig. 3). Is an acetylated form of C-1, and FIG. 4 shows C.
-3 shows the acetylated form).
(2)測定条件 C−1及びC−3のアセチル化体は、高速液体クロマト
グラフィー(カラム:島律社製 Shimpack HSG−20、移
動相:テトラヒドロフラン、検出:紫外線分光光度計25
0nm)で実施した。尚、標準物質にはポリスチレンを用
いて測定した。(2) Measurement conditions The acetylated products of C-1 and C-3 were analyzed by high performance liquid chromatography (column: Shimamitsu Shimpack HSG-20, mobile phase: tetrahydrofuran, detection: ultraviolet spectrophotometer 25).
0 nm). The standard substance was measured using polystyrene.
(3)分子量の測定結果 C−1のアセチル化体は分子量3,500〜5,500、一方、C
−3のアセチル化体の方は2,500〜3200であることが確
認された。(3) Measurement result of molecular weight The acetylated form of C-1 has a molecular weight of 3,500 to 5,500, while C
It was confirmed that the acetylated form of -3 was 2,500 to 3,200.
以上、本発明によるヤシャブシの堅果から得られた抗紫
外線誘発突然変異作用組成物の有する特徴を、理化学的
に求めることによって特定することが出来たことから、
以後、本成分の製造に当っては、カバノキ科植物のヤシ
ャブシ(Alnus firma Sied et Zucc.)の植物体及び堅
果、その組織培養法による抽出、精製による製造が可能
となった。As described above, since the characteristics of the anti-ultraviolet-induced mutagenesis composition obtained from the nuts and nuts of the present invention can be specified by physicochemically determining,
After that, in the production of this component, it became possible to produce plants and nuts of Alnus firma Sied et Zucc., A birch plant, by extraction and purification by the tissue culture method.
尚、次表(第1表)は、前記、各項目による試験の結果
をまとめたものである。The following table (Table 1) is a summary of the results of the tests according to the above items.
〔4〕作用又は効果に関する試験 本発明によるC−1及びC−3の抗変異原性作用の評価
に当っては、望月、賀田の方法(Mutation Reseach,Vo
l.95,P457(1982))に従い、紫外線の照射方法及び検
体を加えた後の浸とう時間について一部改良して実施し
た。その測定法は次の通りである。 [4] Test on Action or Effect In evaluating the antimutagenic action of C-1 and C-3 according to the present invention, the method of Mochizuki, Kada (Mutation Reseach, Vo
l.95, P457 (1982)), the irradiation method of ultraviolet rays and the soaking time after adding the specimen were partially improved. The measuring method is as follows.
(1)測定法 (a)使用菌株 Escherichia Coli B/r WP2 trp- (b)紫外線照射法 一晩、前培養した菌を100mMリン酸ナトリウム緩衝液(p
H7.0)で3回洗浄し、同緩衝液中で撹拌しながら、48.6
J/m2の紫外線を照射して(直径90mmのシャーレ、液層約
2mm)で行った。(1) Measurement method (a) using the strain Escherichia Coli B / r WP2 trp - (b) ultraviolet irradiation overnight, precultured fungus a 100mM sodium phosphate buffer (p
H7.0) and washed 3 times with 48.6 while stirring in the same buffer.
Irradiate with UV of J / m 2 (a Petri dish with a diameter of 90 mm, liquid layer approx.
2 mm).
(c)検体(C−1及びC−3)の調整 滅菌した試験管に一定量の検体を入れ、30μのDMSOと
500μの100mMリン酸ナトリウム緩衝液を加える。(C) Preparation of specimens (C-1 and C-3) Put a certain amount of specimen in a sterilized test tube, and add 30μ DMSO.
Add 500 μ of 100 mM sodium phosphate buffer.
(d)変異原性の測定 前記(c)で調整した溶液に、前記(b)で得られた菌
懸濁液100μを加え、37℃、30分間振とうを行い、次
に2.5mlの軟寒天を加えて最小グルコース寒天培地に広
げた後、37℃で、72時間培養する。そして育成したコロ
ニーをもって突然変異した菌と判定する。(D) Measurement of mutagenicity To the solution prepared in (c) above, 100 μ of the bacterial suspension obtained in (b) above was added, shaken at 37 ° C. for 30 minutes, and then 2.5 ml of soft solution was added. After adding agar and spreading it on the minimal glucose agar medium, incubate at 37 ° C for 72 hours. Then, the grown colony is determined to be a mutated bacterium.
生菌数の判定は、37℃、30分間振とうした後の混液を、
100mMリン酸ナトリウム緩衝液で、10の6剰倍(106倍)
に希釈して、前培養用液体培地に寒天を加えた培地に広
げ、37℃、24時間の培養後のコロニー数を生菌数とし
た。To determine the viable cell count, shake the mixed solution at 37 ° C for 30 minutes,
100 mM sodium phosphate buffer, 6 times 10 (10 6 times)
The cells were diluted to 1, spread on a medium containing agar in the preculture liquid medium, and the number of colonies after culturing at 37 ° C. for 24 hours was taken as the viable cell count.
(2)成績結果 C−1及びC−3の抗変異原性作用について、その結果
をそれぞれ次表(第2〜3表)に示す。(2) Results Results The results of the antimutagenic effects of C-1 and C-3 are shown in the following tables (Tables 2 to 3).
尚、各表中、生存率は紫外線無照射において検体無添加
時の生菌数を100%となし、これを基準に求めた。In each table, the survival rate was determined on the basis of the number of viable cells in the absence of ultraviolet light irradiation and without addition of a sample, which was 100%.
一方、各表中、突然変異率は、紫外線照射において検体
無添加時の突然変異頻度を100%となし、これを基準に
求めた。On the other hand, in each table, the mutation rate was calculated based on the mutation frequency of 100% when the sample was not added under UV irradiation, which was used as a standard.
すなわち、本発明において得られたC−1及びC−3
は、これを系中に添加することによって、明らかに突然
変異率が減少すること。That is, C-1 and C-3 obtained in the present invention
Shows that the mutation rate is obviously reduced by adding this to the system.
その生菌数の増加は、C−1においては、0.5mg/plat
e、C−3においては、0.5mg/plateまであらわれるこ
と、特にC−3の1mg/plate当りにおける生菌数は、紫
外線照射前と同じレベルまでに回復することが確認され
た。The increase in the viable cell count was 0.5 mg / plat in C-1.
It was confirmed that e and C-3 appeared up to 0.5 mg / plate, and in particular, the viable cell count per 1 mg / plate of C-3 was recovered to the same level as before the ultraviolet irradiation.
〔5〕安全性 (1)皮膚一次刺激性試験 本発明のC−1およびC−3について、それぞれ5%水
溶液を調整し、背部を除毛した兎(1群3匹,体重3.9k
g前後)の皮膚に貼付した。 [5] Safety (1) Primary skin irritation test With respect to C-1 and C-3 of the present invention, rabbits with 5% aqueous solution prepared and hair removed on their backs (1 group, 3 animals, weight: 3.9 k)
(around g).
判定は、貼布後24,48,72時間に一次刺激性の評点法によ
り紅斑および浮腫を指標として行った。The evaluation was carried out 24, 48, and 72 hours after application by using the erythema and edema as indexes by the primary irritation scoring method.
その結果、C−1およびC−3とも何等、紅斑および浮
腫を認めず陰性と判定された。As a result, neither erythema nor edema was observed in both C-1 and C-3, and it was determined to be negative.
(2)急性毒性試験 試験前4時間絶食させたddYマウス(雄,雌,1群5匹づ
つ,体重30g前後)を使用し、C−1およびC−3とも
に2,000mg/Kg量を水溶液として経口投与し、毒性症状の
発現、程度等を経時的に観察した。(2) Acute toxicity test ddY mice (5 males / female, 5 mice / group, body weight about 30g) that had been fasted for 4 hours before the test were used, and both C-1 and C-3 were 2,000 mg / Kg as an aqueous solution. Oral administration was performed, and the onset and degree of toxic symptoms were observed over time.
その結果、すべてのマウスにおいて14日間何等異常を認
めず、また解剖の結果も異常なし。As a result, all mice showed no abnormalities for 14 days, and the autopsy results were also normal.
LD502,000mg/Kg以上と判定された。The LD 50 was determined to be 2,000 mg / Kg or higher.
〔6〕用途 本発明によるC−1およびC−3は、その優れた効果に
より、特に皮膚や頭髪用の化粧品などのような外用剤と
して好適に使用できる。[6] Use Due to its excellent effects, C-1 and C-3 according to the present invention can be preferably used as an external preparation such as cosmetics for skin and hair.
例えば、ローション,クリーム,乳液といったタイプの
一般に市販されているような各種スキンケア,ヘアーケ
ア製品の処方中に、そのまま又は溶解液となしたものを
常用される基剤とともに配合すればよい。For example, in the formulation of various commercially available skin care and hair care products such as lotions, creams and emulsions, it may be blended as it is or as a solution with a commonly used base.
また、健康食品,加工食品,菓子類,飲料などのような
食品類にももちろん応用可能であるが、その場合につい
ても、他の原料と共に混合し常法にしたがって製造すれ
ばよい。Further, it is of course applicable to foods such as health foods, processed foods, confectionery, beverages, etc., and in that case, it may be prepared by mixing with other raw materials according to a conventional method.
その他、本剤を賦形剤などで固め、適当な顆粒あるいは
錠剤などとしてもよい。In addition, the agent may be solidified with an excipient or the like to give an appropriate granule or tablet.
「発明の効果」 本発明により得られたC−1及びC−3は、前記第1〜
2表にそれぞれ示したごとく、抗紫外線誘発突然変異作
用剤として評価された。"Effect of the invention" C-1 and C-3 obtained by the present invention are the above
As shown in Table 2, each was evaluated as an anti-UV-induced mutagen.
すなわち、その作用についてまとめてみると、 次のごとく述べることが出来る。That is, the action can be summarized as follows.
(1) C−1又はC−3は、共に紫外線の照射によって誘発す
る突然変異を著明に抑制する。(1) Both C-1 and C-3 remarkably suppress the mutation induced by irradiation with ultraviolet rays.
(2) C−1又はC−3は、前記、作用又は効果に関する試験
の結果からわかるように、非常に低濃度においても紫外
線に照射された大腸菌の生存率を著明に上昇させる。(2) C-1 or C-3 remarkably increases the survival rate of Escherichia coli irradiated with ultraviolet rays even at a very low concentration, as can be seen from the results of the above-mentioned test for action or effect.
(3) この作用は紫外線によって誘発されたDNAの損傷を効率
よく修復し、正常に戻すためと考えられる。(3) It is considered that this action is for efficiently repairing the DNA damage induced by ultraviolet light and returning it to the normal state.
そして、この作用は特にC−3において強く現われる。And, this effect is particularly strong in C-3.
よって、本発明によるC−1又はC−3の応用分野は、
例えば医薬品、化粧品、食品、あるいは醗酵工業、遺伝
子工学等を用いた医薬の開発等への利用が可能である。Therefore, the application field of C-1 or C-3 according to the present invention is
For example, it can be used for the development of pharmaceuticals, cosmetics, foods, or pharmaceuticals using the fermentation industry, genetic engineering and the like.
又、医薬品や化粧品あるいは食品分野への応用に当って
は、C−1、C−3は必ずしもその精製物を用いること
を必要とせず、例えば、前項において示した、粗抽出
物、あるいは粗C−1粗C−3を用いることは十分可能
なことである。Further, in application to the fields of medicines, cosmetics or foods, it is not always necessary to use the purified product of C-1 and C-3. It is quite possible to use -1 crude C-3.
すなわち、本発明者らの研究は、ヤシャブシの堅果中か
ら抽出したエキス中に、抗紫外線誘発突然変異作用を有
する成分が存在することを見いだし、それが如何なる物
質であるかその追求に当り同定に成功し、本発明を完成
するに至ったわけであるが、従来、このようなC−1又
はC−3について、抗変異原性作用があることは全く知
られておらず、本発明の成功は植物(天然物)の有効利
用を促進するものとして、そのもたらす効果は大きいも
のと考える。That is, the present inventors' study found that there was a component having an anti-ultraviolet-induced mutagenesis effect in the extract extracted from the nuts of Yasbushi, and to identify what kind of substance it was. Although it succeeded and came to complete the present invention, conventionally, it was not known at all that such C-1 or C-3 has an antimutagenic effect, and the success of the present invention was It is thought that the effect that it brings is great as it promotes the effective use of plants (natural products).
第1図は、C−1の赤外線吸収スペクトル。 第2図は、C−3の赤外線吸収スペクトル。 第3図は、C−1のアセチル化体の赤外線吸収スペクト
ルである。 第4図は、C−3のアセチル化体の赤外線吸収スペクト
ルである。FIG. 1 is an infrared absorption spectrum of C-1. FIG. 2 is an infrared absorption spectrum of C-3. FIG. 3 is an infrared absorption spectrum of the acetylated form of C-1. FIG. 4 is an infrared absorption spectrum of the acetylated form of C-3.
Claims (3)
された、次の(a)〜(c)の性質を有する縮合型タン
ニン分画を有効成分とする抗紫外線誘発突然変異作用
剤。 (a)水に易溶、エタノール、酢酸エチル、クロロホル
ムには不溶。 (b)アセチル体となすとき、その分子量が3,500〜5,5
00にある。 (c)薄層クロマトグラムのRf値が0.35付近。 薄層板:254nm UV光下蛍光発色型親水性シリカゲルプレ
ート 展開溶媒:クロロホルム:メタノール:酢酸(3:2:0.
2)混液1. An anti-ultraviolet ray-inducing mutagenizing agent, which comprises, as an active ingredient, a condensed tannin fraction having the following properties (a) to (c), which is extracted from the seeds of Yabushiboshi, a birch plant. (A) Easily soluble in water, insoluble in ethanol, ethyl acetate and chloroform. (B) When made into an acetyl form, its molecular weight is 3,500 to 5,5.
It's at 00. (C) The Rf value of the thin-layer chromatogram is around 0.35. Thin layer plate: 254nm UV fluorescent hydrophilic silica gel plate Developing solvent: Chloroform: Methanol: Acetic acid (3: 2: 0.
2) Mixed liquid
された、次の(a)〜(c)の性質を有する縮合型タン
ニン分画を有効成分とする抗紫外線誘発突然変異作用
剤。 (a)水にやや難溶、エタノールに易溶、酢酸エチル、
クロロホルムには不溶。 (b)アセチル体となすとき、その分子量が2,500〜3,2
00にある。 (c)薄層クロマトグラムのRf値が0.54付近。 薄層板:254nm UV光下蛍光発色型親水性シリカゲルプレ
ート 展開溶媒:クロロホルム:メタノール:酢酸(3:2:0.
2)混液2. An anti-ultraviolet ray-inducing mutagenizing agent, which comprises, as an active ingredient, a condensed tannin fraction having the following properties (a) to (c), which is extracted from the scabbard fruit of the Birchaceae plant. (A) Slightly insoluble in water, easily soluble in ethanol, ethyl acetate,
Insoluble in chloroform. (B) When made into an acetyl form, its molecular weight is 2,500 to 3,2.
It's at 00. (C) The Rf value of the thin-layer chromatogram is around 0.54. Thin layer plate: 254nm UV fluorescent hydrophilic silica gel plate Developing solvent: Chloroform: Methanol: Acetic acid (3: 2: 0.
2) Mixed liquid
された請求項第1項記載の縮合型タンニン分画と、請求
項第2項記載の縮合型タンニン分画の混合物を有効成分
とする抗紫外線誘発突然変異作用剤。3. An antibacterial composition comprising a mixture of the condensed tannin fraction according to claim 1 and the condensed tannin fraction according to claim 2, which is extracted from the seeds of the genus Yabushi of the Birchaceae plant. UV-induced mutagen.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63271820A JPH0686389B2 (en) | 1988-10-26 | 1988-10-26 | Anti-UV-induced mutagenic agent derived from Yashabushi fruit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63271820A JPH0686389B2 (en) | 1988-10-26 | 1988-10-26 | Anti-UV-induced mutagenic agent derived from Yashabushi fruit |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH02117685A JPH02117685A (en) | 1990-05-02 |
| JPH0686389B2 true JPH0686389B2 (en) | 1994-11-02 |
Family
ID=17505304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63271820A Expired - Fee Related JPH0686389B2 (en) | 1988-10-26 | 1988-10-26 | Anti-UV-induced mutagenic agent derived from Yashabushi fruit |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0686389B2 (en) |
-
1988
- 1988-10-26 JP JP63271820A patent/JPH0686389B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH02117685A (en) | 1990-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ye et al. | Antioxidant activities of an exopolysaccharide isolated and purified from marine Pseudomonas PF-6 | |
| Jabeen et al. | An insight into biochemical characterization and explorations of antioxidant, antibacterial, cytotoxic, and antidiabetic activities by trachyspermum ammi nanosuspensions | |
| JP2004059566A (en) | Natural antibacterial agent | |
| JP6273614B2 (en) | Hesperetin derivative exhibiting gene repair activating action and method for producing the same | |
| JP6369751B2 (en) | Curcumin derivative exhibiting keratin producing action and method for producing the same | |
| WO1998056755A1 (en) | Physiologically active substances tkr2449, process for producing the same, and microorganism | |
| JP2009280514A (en) | Organic acid peptide-bonded luteolin derivative exhibiting anti-oxidizing action and method for producing the same | |
| JP3031844B2 (en) | Hydroxy radical scavenger | |
| JP6627045B2 (en) | Polyphenol derivatives exhibiting stem cell factor receptor activating action | |
| JPH08208685A (en) | Hydroxyl radical scavenging activator | |
| JPH0686389B2 (en) | Anti-UV-induced mutagenic agent derived from Yashabushi fruit | |
| CN110862463A (en) | Preparation of alfalfa root polysaccharide with bioactivity and selenizing modified polysaccharide thereof | |
| CN109081863A (en) | The isolation and identification method of anti-cancer active matter D actinomycin D FGR | |
| JP2884104B2 (en) | Anti-mutagenic agent derived from salamander | |
| JPH09110712A (en) | Tea saponin antifungal agent | |
| JPH08231539A (en) | New lignan glycoside | |
| JPH09315992A (en) | Suppressor of mutation induced by ultraviolet light | |
| CN115192621B (en) | Prebiotics embedded with acylated honeysuckle extract, preparation method and application | |
| KR0152738B1 (en) | Antioxidant and Chromosome Abnormal Inhibitor with Gompi Extract | |
| JPH0816062B2 (en) | Anti-mutagenic agent derived from fennel | |
| JPH08325289A (en) | Method for producing new lignan glycoside | |
| JPH07145066A (en) | Method for producing lignan glycosides and lignans | |
| Al-Maliki et al. | Characterization and Evaluation of Medicinal Activity of Three Phenolic Compounds From Iraqi Juglans regia L. Cortex Against Pathogenic Fungi Causing Intestinal Inflammatory in Children | |
| JP2754313B2 (en) | Indene derivative and antibacterial agent containing the same as an active ingredient | |
| JPH0543445A (en) | Skin medicine for external use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313532 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313532 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |